HUYA Bioscience International
Industry
- Biotechnology
- Pharmaceuticals
- Specialty Pharmaceuticals
- Vaccines
Other Names/Subsidiaries
- Huya Japan G.K.
- HUYABIO International
Latest on HUYA Bioscience International
The third quarter of 2021 has marked a new chapter for Chinese biotechs’ ambitions to take on the world. Leading players BeiGene, Ltd. and HUTCHMED (China) Limited (previously Chi-Med) have been b
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. LianBio Launch Includes Deals With MyoK
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . BeiGene Picks Up Asia Rights
On 13 June, Chinese Vice Premier He Liu and other top officials opened a new chapter for the Shanghai Stock Exchange. In a high-profile ceremony, Liu unveiled the Science and Technology Board, a stock